Transplant and Cellular Therapy Program

The Transplant and Cellular Therapy Program is conducted in conjunction with the Rutgers Cancer Institute. The team performs stem cell transplants for patients with a variety of illnesses:

  • Acute and chronic leukemias
  • Myelodysplasia
  • Various types of lymphoma
  • Hodgkin's disease
  • Multiple myeloma
  • Amyloidosis and related diseases

Both autologous and allogeneic transplants are performed.

The sources of transplant include matched siblings as well as matched unrelated donors and umbilical cord blood. There are several research initiatives within the Transplant and Cellular Therapy program. In addition to participating in national and international clinical research studies with other transplant centers, there are unique research programs focusing on novel ways to: prevent graft-versus-host disease; improve umbilical cord blood transplants; and develop novel cellular therapies with less toxicity than standard transplants.

The program is certified by FACT as well as the National Marrow Donor Program.

Patient Stories

  • “Getting a transplant has changed my life completely. I am very grateful.”

    Marcela
    Read More

  • “I tell him he’s Superman and he can do no wrong,” Brian says. “It’s such a great gesture that it’s hard to put into words and say something that would do it justice.”

    Brian
    Read More

  • “The Impella 5.5 was a life-saving device for me,” Keith added. “When I went into the hospital I did not know if or how I was going to have the opportunity to receive a heart. The Impella 5.5 made that possible for me.”

    Keith
    Read More

Patient Stories

  • Watch Testimonial
  • Watch Testimonial
  • Watch Testimonial